Whittier Trust’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Whittier Trust’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-190	Closed	-$2K	–	1577
2021 Q1	$2K	Buy	+190	New	+$2.67K	﹤0.01%	1463

Other funds holding PRVB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Whittier Trust's PRVB Position: Q2 2021 in Review

Whittier Trust sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2021, closing a stake of 190 shares — an estimated $2K sold.

Whittier Trust first reported a position in PRVB in Q1 2021 and held it in 1 quarter. The position peaked at $2K in Q1 2021. 125 funds tracked by Wall St. Rank hold PRVB as of Q2 2021.

Whittier Trust reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Whittier Trust sold 190 Provention Bio, Inc. Common Stock shares in Q2 2021, an estimated $2K.
Whittier Trust first reported a position in Provention Bio, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
Whittier Trust's Provention Bio, Inc. Common Stock position peaked at $2K in Q1 2021.
125 funds tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2021.

Based on Whittier Trust's 13F filing for Q2 2021, filed 29 Jul 2021.